HomeHLS • TSE
add
HLS Therapeutics Inc
Previous close
$4.29
Day range
$4.31 - $4.40
Year range
$3.90 - $5.77
Market cap
137.60M CAD
Avg Volume
13.33K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 15.20M | -2.23% |
Operating expense | 10.68M | -8.07% |
Net income | -1.34M | 55.84% |
Net profit margin | -8.79 | 54.81% |
Earnings per share | -0.04 | 60.00% |
EBITDA | 5.18M | 11.25% |
Effective tax rate | 32.64% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.72M | -32.84% |
Total assets | 137.53M | -13.99% |
Total liabilities | 75.86M | -14.34% |
Total equity | 61.67M | — |
Shares outstanding | 31.27M | — |
Price to book | 2.18 | — |
Return on assets | 0.43% | — |
Return on capital | 0.52% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.34M | 55.84% |
Cash from operations | 6.51M | 103.03% |
Cash from investing | -316.00K | -2,330.77% |
Cash from financing | -5.37M | -102.26% |
Net change in cash | 945.00K | 1,225.00% |
Free cash flow | 6.69M | 55.98% |
About
Founded
2014
Website
Employees
85
